Mobile MTM developer receives NIH grant
CHICAGO – A company developing mobile medication therapy management technology got a big boost from the federal government.
Leap of Faith Technologies announced that it had received a grant worth more than $1 million from the National Cancer Institute, part of the National Institutes of Health, to develop its eMedonline software-as-service mHealth mobile-health platform for iPhone and Android devices. The company said the platform improves medication adherence, monitors outcomes and provides opportunities for drug surveillance and research data mining, saying the platform had demonstrated medication adherence levels of 98%, along with “significant” improvements in patient self-efficacy in NIH- and industry-funded clinical trials.
The company hopes to use the grant to bring its technology to the marketplace, and an industry partner will match the NIH grant to connect the platform to an electronic health record system.
Leap of Faith founder and chief science officer Barbara Rapchak said, “eMedonline represents the convergence of mobile technology, clinical and behavioral science and validated clinical outcomes in a mHealth platform that facilitates coordinated care and also supports meaningful use.”